What's breaking now, across thousands of outlets.
The acquisition of Texas-based IntraBio adds to a growing rare disease business for Shionogi by handing the company a marketed treatment for two inherited conditions.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
The NHS may not be able to replace Palantir before a crunch deadline on its £330m data contract, raising the stakes for ministers as pressure mounts to cut ties with the US tech giant.
A laboratory worker at a plague research institute in Siberia has fallen ill and died in undisclosed circumstances, prompting authorities to quarantine dozens of people.
Ken Paxton, the Texas attorney general and Republican Senate candidate, has alleged a sprawling profit-driven conspiracy. Pediatricians say the accusations are an attempt at intimidation.
Residents of the Banda District in the Bono Region can now access National Health Insurance Scheme (NHIS) services within the district following the commissioning of a new National Health Insurance…
Secretary of State Marco Rubio told reporters Monday that the U.S. is monitoring a possible plague outbreak in Russia after a lab worker died.
Exposure to GLP-1 weight-loss and diabetes drugs around conception is not linked to a clearly detectable increase in adverse outcomes for mothers or babies, according to the largest study of its kind…
